MYGN — Myriad Genetics, Inc. stock price, charts and financials

QT37Myriad Genetics, Inc.

Myriad Genetics, Inc. (NASDAQ: MYGN) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.25
-0.01-0.31%
OverviewShort InterestFilings
MYGNQT37Myriad Genetics, Inc.·NASDAQ
3.25-0.31%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 04, 2026S-8Registration of employee benefit securities
Jun 04, 2026S-8Registration of employee benefit securities
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20263Initial statement of beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 06, 202610-QQuarterly report
May 05, 20268-KCurrent report
#1 / 25 of 503
Page
▼
/ 21